CD8A and neoplasm: A previous study examined the targeted delivery of α-GalCer to CD8α+ DCs via anti-DEC205 decorated nanoparticles in an attempt to improve iNKT cell-based anti-tumor responses in a murine B16-F10 melanoma model [92].